Cancer Risk Assessment for the Primary Care Physician

Overview

Journal Prim Care

Specialties General Medicine
Public Health

Date 2009 Jul 21

PMID 19616151

Citations 3

Authors

Larissa A Korde

Shahinaz M Gadalla

Affiliations

Soon will be listed here.

Abstract

Cancer is the second leading cause of death in the United States. Cancer risk assessment can be divided into two major categories: assessment of familial or genetic risk and assessment of environmental factors that may be causally related to cancer. Identification of individuals with a suspected heritable cancer syndrome can lead to additional evaluation and to interventions that can substantially decrease cancer risk. Special attention should also be paid to potentially modifiable cancer risk factors in the course of advising primary care patients regarding a healthy lifestyle. Clinical guidelines, targeting both genetic and modifiable cancer risk factors, are available and can facilitate the application of these health care principles in the primary care setting.

Citing Articles

Early identification of people at high risk of oral cancer-A review of existing risk prediction models.

Mocherla M, Krishnappa P J Family Med Prim Care. 2024; 13(8):2851-2856.

PMID: 39228608 PMC: 11368278. DOI: 10.4103/jfmpc.jfmpc_117_24.

Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters.

Nguyen T, Huang P, Chu P, Hsieh C, Wu M Cancers (Basel). 2023; 15(22).

PMID: 38001632 PMC: 10670359. DOI: 10.3390/cancers15225372.

Utilization of a breast cancer risk assessment tool by internal medicine residents in a primary care clinic: impact of an educational program.

Yadav S, Hartkop S, Cardenas P, Ladkany R, Halalau A, Shoichet S BMC Cancer. 2019; 19(1):228.

PMID: 30871497 PMC: 6416938. DOI: 10.1186/s12885-019-5418-6.

References

Kushi L, Byers T, Doyle C, Bandera E, McCullough M, McTiernan A . American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2006; 56(5):254-81. DOI: 10.3322/canjclin.56.5.254. View

Balmana J, Stockwell D, Steyerberg E, Stoffel E, Deffenbaugh A, Reid J . Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA. 2006; 296(12):1469-78. DOI: 10.1001/jama.296.12.1469. View

Fears T, Guerry 4th D, Pfeiffer R, Sagebiel R, Elder D, Halpern A . Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol. 2006; 24(22):3590-6. DOI: 10.1200/JCO.2005.04.1277. View

Mihalynuk T, Scott C, Coombs J . Self-reported nutrition proficiency is positively correlated with the perceived quality of nutrition training of family physicians in Washington State. Am J Clin Nutr. 2003; 77(5):1330-6. DOI: 10.1093/ajcn/77.5.1330. View

Freedman A, Slattery M, Ballard-Barbash R, Willis G, Cann B, Pee D . Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2008; 27(5):686-93. PMC: 2645090. DOI: 10.1200/JCO.2008.17.4797. View

Calfas K, Long B, Sallis J, Wooten W, Pratt M, Patrick K . A controlled trial of physician counseling to promote the adoption of physical activity. Prev Med. 1996; 25(3):225-33. DOI: 10.1006/pmed.1996.0050. View

Kauff N, Satagopan J, Robson M, Scheuer L, Hensley M, Hudis C . Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002; 346(21):1609-15. DOI: 10.1056/NEJMoa020119. View

Lewis B, Lynch W . The effect of physician advice on exercise behavior. Prev Med. 1993; 22(1):110-21. DOI: 10.1006/pmed.1993.1008. View

Bishop D, Demenais F, Goldstein A, Bergman W, Bishop J, Bressac-de Paillerets B . Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst. 2002; 94(12):894-903. DOI: 10.1093/jnci/94.12.894. View

10.

Acheson L, Wiesner G, Zyzanski S, Goodwin M, Stange K . Family history-taking in community family practice: implications for genetic screening. Genet Med. 2001; 2(3):180-5. DOI: 10.1097/00125817-200005000-00004. View

11.

Costantino J, Gail M, Pee D, Anderson S, Redmond C, Benichou J . Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999; 91(18):1541-8. DOI: 10.1093/jnci/91.18.1541. View

12.

Rebbeck T, Friebel T, Lynch H, Neuhausen S, van t Veer L, Garber J . Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004; 22(6):1055-62. DOI: 10.1200/JCO.2004.04.188. View

13.

Boland C, Thibodeau S, Hamilton S, Sidransky D, Eshleman J, Burt R . A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998; 58(22):5248-57. View

14.

Parker E, Folsom A . Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study. Int J Obes Relat Metab Disord. 2003; 27(12):1447-52. DOI: 10.1038/sj.ijo.0802437. View

15.

King M, Wieand S, Hale K, Lee M, Walsh T, Owens K . Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA. 2001; 286(18):2251-6. DOI: 10.1001/jama.286.18.2251. View

16.

Lynch H, de la Chapelle A . Hereditary colorectal cancer. N Engl J Med. 2003; 348(10):919-32. DOI: 10.1056/NEJMra012242. View

17.

Vogel V, Costantino J, Wickerham D, Cronin W, Cecchini R, Atkins J . Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006; 295(23):2727-41. DOI: 10.1001/jama.295.23.joc60074. View

18.

Stead L, Bergson G, Lancaster T . Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008; (2):CD000165. DOI: 10.1002/14651858.CD000165.pub3. View

19.

Lynch H, Lynch J, Lynch P, Attard T . Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer. 2007; 7(1):27-39. DOI: 10.1007/s10689-007-9165-5. View

20.

La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E . Epidemiology and prevention of oral cancer. Oral Oncol. 1998; 33(5):302-12. DOI: 10.1016/s1368-8375(97)00029-8. View